Drug intelligence / Profile preview

pp-PA83

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

**pp-PA83** is a plant-produced, precursor form of the 83 kDa protective antigen (PA83) from *Bacillus anthracis*, engineered in *Nicotiana benthamiana* for use in anthrax subunit vaccines. It consists of a pro-protein (pp) version that requires processing to mature PA63 for full activity, but glycosylation in plants impairs its biological function and stability. Co-expression with peptide-N-glycosidase F enables *in vivo* deglycosylation to produce the active, non-glycosylated variant pp-dPA83, which exhibits comparable *in vitro* cell-binding and pore-forming activity to prokaryotic rPA83, induces superior toxin-neutralizing antibodies in mice, and demonstrates enhanced thermostability. Developed as a low-cost, scalable vaccine antigen candidate, it adsorbs effectively to Alhydrogel adjuvant via electrostatic interactions without major structural disruption, supporting its potential for mass immunization against anthrax bioterrorism.[3][6]

Other names
rPA83rPA-83rPA 83
02

Targets

ANTXR2 (Anthrax toxin receptor 2)ANTXR1 (Anthrax toxin receptor 1)

Beyond the preview

Go deeper on pp-PA83.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pp-PA83.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call